India's Panacea Biotec hits upper circuit on contracts worth $127 mln

Panacea Biotec

11/10/2022 05:18

** Shares of Panacea Biotec Ltd  PNCA.NS  rise as much as
20% to hit upper circuit at 160.80 rupees
    ** The biotechnology co said on Monday it received long-term
supply contracts worth $127.30 mln from UNICEF and Pan American
Health Organization  urn:newsml:reuters.com:*:nFWN31B2BQ
    ** The supply award is for World Health Organization's
pre-qualified fully liquid Pentavalent vaccine 
    ** Stock rises for a second session, marks its biggest
intraday pct gain since Dec 2, 2020
    ** More than 477,000 shares change hands, 7.1 times their
30-day avg of 67,483 shares
    ** Panacea stock down 32.54% YTD, as of last close
 (Reporting by Nishit Navin in Bengaluru)
 ((nishit.navin@thomsonreuters.com;))